veratrine and vesnarinone

veratrine has been researched along with vesnarinone* in 3 studies

Other Studies

3 other study(ies) available for veratrine and vesnarinone

ArticleYear
Action-potential duration and contractility in canine cardiac tissues: action of inotropic drugs.
    General pharmacology, 1998, Volume: 31, Issue:3

    1. Inotropic and electrophysiologic effects of veratrine, vesnarinone, d-sotalol and tetraethylammonium (TEA) were compared. Action-potential duration (APD) and contractility were measured in isolated canine Purkinje fiber and ventricular trabecular muscle preparations by using standard microelectrode techniques. Each drug significantly increased APD and force development in either tissue. 2. Drug-induced increases in force development were normalized to increases in APD. The order of efficacy was found to be vesnarinone>veratrine>TEA in ventricular myocardium, whereas it was veratrine>>vesnarinone=d-sotalol=TEA in Purkinje fibers. 3. The force-APD relation was linear for all drugs in the concentrations used. 4. Simultaneous measurements of APD, force development and intracellular sodium ion activity (a(i)Na) in the presence of either veratrine or lidocaine indicated a linear relation between force development and changes in a(i)Na. 5. The relation between APD and force development was different in ventricular and Purkinje fiber preparations. Differences in the veratrine sensitivity of the force-APD relation observed between Purkinje and ventricular preparations suggest that a(i)Na-dependent changes in Na+/Ca2+ exchange may play a more important role in regulation of force generation in Purkinje fibers than in ventricular myocardium.

    Topics: Action Potentials; Animals; Cardiotonic Agents; Dogs; Female; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Purkinje Fibers; Pyrazines; Quinolines; Sodium; Sotalol; Tetraethylammonium; Veratrine

1998
Ionic basis for OPC-8212-induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes.
    European journal of pharmacology, 1993, Aug-24, Volume: 240, Issue:2-3

    Changes in transmembrane ionic currents induced by OPC-8212 (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline) , a recently introduced positive inotropic agent which lengthens cardiac action potential duration, were examined using whole-cell voltage-clamp techniques in single rabbit, guinea pig and human ventricular myocytes. In rabbit, OPC-8212 (12 mumol/l) significantly increased membrane action potential duration measured at 90% of repolarization by an average of 88 ms (from 462 +/- 25 to 550 +/- 35 ms, n = 4; P < 0.05). In rabbit this increase in duration was not associated with significant changes in either the inward rectifier or transient outward K+ currents. The magnitude of the secondary inward current evoked from a holding potential of -50 mV was significantly increased by 97 +/- 8% (n = 6; P < 0.01) while a demonstrable delayed rectifier outward current could not be identified in the rabbit myocytes examined at room temperature. In guinea pig ventricular myocytes, where the delayed rectifier was large, 12 mumol/l OPC-8212 significantly depressed the current by 58 +/- 10% (n = 6; P < 0.01). The effects of OPC-8212 in human ventricular myocytes obtained from the explanted heart of a single patient having an idiopathic cardiomyopathy most closely resembled those observed in isolated rabbit ventricular myocytes. Thus, in rabbit and a few human ventricular myocytes examined at room temperature, OPC-8212 appeared to lengthen cardiac membrane action potential duration primarily by increasing the amplitude of the secondary inward current believed to primarily represent current through L-type Ca2+ channels. In guinea pig preparations, OPC-8212 also decreased the delayed rectifier outward K+ current which also would account for an increase in action potential duration. OPC-8212 could not be demonstrated to affect Na+ current inactivation in a manner similar to that produced by 1 mg/l veratrine, a recognized Na+ channel agonist, which dramatically slowed this process.

    Topics: Action Potentials; Animals; Cardiotonic Agents; Electrophysiology; Female; Guinea Pigs; Heart; Heart Ventricles; Humans; In Vitro Techniques; Male; Membrane Potentials; Myocardial Contraction; Potassium; Pyrazines; Quinolines; Rabbits; Sodium; Veratrine

1993
Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212.
    European journal of pharmacology, 1985, Nov-19, Volume: 117, Issue:3

    Topics: Animals; Biological Transport; Calcium; Cardiotonic Agents; Electrophysiology; Guinea Pigs; In Vitro Techniques; Ion Channels; Lidocaine; Myocardium; Purkinje Fibers; Pyrazines; Quinolines; Sodium; Veratrine

1985